Chronic and subacute meningitis

CONTINUUM Lifelong Learning in Neurology

Volumn 18, Issue 6, 2012, Pages 1290-1318

  Zunt, Joseph R ^a   Baldwin, Kelly J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; AMPICILLIN; AZATHIOPRINE; CEFTRIAXONE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ETHAMBUTOL; FLUCONAZOLE; FLUCYTOSINE; HYDROXYCHLOROQUINE; INFLIXIMAB; ISONIAZID; METHOTREXATE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID; PENICILLIN G DERIVATIVE; PREDNISONE; PROBENECID; PROCAINE PENICILLIN; PYRAZINAMIDE; RIFAMPICIN; STEROID; STREPTOMYCIN; UNINDEXED DRUG; VANCOMYCIN; VORICONAZOLE;

ASPERGILLOSIS; AUTOIMMUNE DISEASE; BEHCET DISEASE; BLASTOMYCOSIS; BLEEDING; BRAIN ISCHEMIA; BRAIN VASCULITIS; CARCINOMATOUS MENINGITIS; CENTRAL NERVOUS SYSTEM ASPERGILLOSIS; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; COCCIDIOIDOMYCOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CRYPTOCOCCAL MENINGITIS; CYTOREDUCTIVE SURGERY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG MEGADOSE; HISTOPLASMOSIS; HUMAN; HYDROCEPHALUS; INTRACRANIAL HYPERTENSION; INVASIVE ASPERGILLOSIS; LUMBAR PUNCTURE; MENINGITIS; MYCOBACTERIOSIS; NEUROSYPHILIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; REVIEW; SARCOIDOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE; TUBERCULOUS MENINGITIS;

ACUTE DISEASE; ADULT; ANTIFUNGAL AGENTS; BEHCET SYNDROME; BLASTOMYCOSIS; CENTRAL NERVOUS SYSTEM DISEASES; CHRONIC DISEASE; COCCIDIOIDOMYCOSIS; EARLY DETECTION OF CANCER; FATAL OUTCOME; FEMALE; HISTOPLASMOSIS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MENINGEAL CARCINOMATOSIS; MENINGITIS; MENINGITIS, BACTERIAL; MENINGITIS, CRYPTOCOCCAL; MENINGITIS, FUNGAL; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NEUROASPERGILLOSIS; NEUROSYPHILIS; SARCOIDOSIS; TUBERCULOSIS, MENINGEAL; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 84871974406     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000423848.17276.21     Document Type: Review

References (80)

1. Mitchell TG, Perfect Jr. Cryptococcosis in the era of AIDSV100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995;8(4):515Y548
2. Chayakulkeeree M, Perfect Jr. Cryptococcosis. Infect Dis Clin North Am 2006;20(3):507Y544, vYvi
3. Pukkila-Worley R, Mylonakis E. Epidemiology and management of cryptococcal meningitis: Developments and challenges. Expert Opin Pharmacother 2008;9(4):551Y560
4. Chen S, Sorrell T, Nimmo G, et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis 2003;31(2):499Y508
5. Mamidi A, DeSimone JA, Pomerantz RJ. Central nervous system infections in individuals with HIV-1 infection. J Neurovirol 2002;8(3):158Y167
6. Mwaba P, Mwansa J, Chinty C, et al. Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions. Postgrad Med J 2001;77(914):769Y773
7. Powderly WG. Current approach to the acute management of cryptococcal infections. J Infect 2000;41(1):18Y22
8. Day J. Cryptococcal meningitis. Pract Neurol 2004;4:274Y285
9. Seaton RA, Verma N, Naraqi S, et al. Visual loss in immunocompetent patients with Cryptococcus neoformans var. gattii meningitis. Trans R Soc Trop Med Hyg 1997;91(1):44Y49
10. Graybill JR, Sobel J, Saag M, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis 2000;30(1): 47Y54
11. Van der Horst CM, Saag MS, Cloud GA, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of llergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. New Engl J Med 1997;337(1):15Y21
12. Lu CH, Chang WN, Chang HW, Chuang YC. The prognostic factors of cryptococcal meningitis in HIV-negative patients. J Hosp Infect 1999;42(4):313Y320
13. Leenders ACAP, Reiss P, Portegies P, et al. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis. AIDS 1997;11(12): 1463Y1471
14. Vibhagool A, Sungkanuparph S, Mootsikapun P, et al. Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virusYinfected patients treated with highly active antiretroviral therapy: A prospective, multicenter, randomized study. Clin Infect Dis 2003;36(10): 1329Y1331
15. Newton PN, Thai LH, Tip NQ, et al. A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in ryptococcal meningitis. Clin Infect Dis 2002;35(6):796Y772
16. Macsween KF, Bicanic T, Brouwer AE, et al. Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: Case report and review. J Infect 2005;51(4):e221Ye224
17. Woodworth GF, McGirt MJ, Williams MA, Rigamonti D. The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension without ventriculomegaly secondary to HIV-associated cryptococcal meningitis. Surg Neurol 2005;63(6):529Y531; discussion 531Y532
18. Parish JM, Blair JE. Coccidioidomycosis. Mayo Clin Proc 2008;83(3):343Y348; quiz 348Y349
19. Drake KW, Adam RD. Coccidioidal meningitis and brain abscesses: Analysis of 71 cases at a referral center. Neurology 2009;73(21):1780Y1786
20. Ampel NM. Coccidioidomycosis in persons infected with HIV type 1. Clin Infect Dis 2005;41(8):1174Y1178
21. Arsura EL, Johnson R, Penrose J, et al. Neuroimaging as a guide to predict outcomes for patients with coccidioidal meningitis. Clin Infect Dis 005;40(4):624Y627
22. Blair JE. Coccidioidal meningitis: Update on epidemiology, clinical features, diagnosis, and management. Curr Infect Dis Rep 2009;11(4):289Y295
23. Ragland AS, Arusa E, Ismail Y, Johnson R. Eosinophilic pleocytosis in coccidioidal meningitis: Frequency and significance. Am J Med 1993;95(3):254Y257
24. Powers CN. Diagnosis of infectious diseases: A cytopathologist's perspective. Clin Microbiol Rev 1998;11(2):341Y365
25. Erly WK, Bellon RJ, Seeger JF, Carmody RF. MR imaging of acute coccidioidal meningitis. AJNR Am J Neuroradiol 1999;20(3):509Y514
26. Galgiani JN, Ampel NM, Blair JE, et al. Coccidioidomycosis. Clin Infect Dis 2005; 41(9):1217Y1223
27. Johnson RH, Einstein HE. Amphotericin B and coccidioidomycosis. Ann NY Acad Sci 2007;1111:434Y441
28. McKinnell JA, Pappas PG. Blastomycosis: New insights into diagnosis, prevention, and treatment. Clin Chest Med 2009;30(2):227Y239, v.
29. Roos KL, Bryan JP, Maggio WW, et al. Intracranial blastomycoma. Medicine (Baltimore) 1987;66(3):224Y235
30. Lemos LB, Guo M, Baliga M. Blastomycosis: Organ involvement and etiological diagnosis. A review of 123 patients from Mississippi. Ann Diagn Pathol 2000;4(6): 391Y406
31. Saccente M, Woods GL. Clinical and laboratory update on blastomycosis. Clin Microbiol Rev 2010;23(2):367Y381
32. Bradsher RW, Chapman SW, Pappas PG. Blastomycosis. Infect Dis Clin North Am 2003;17(1):21Y40, vii
33. Durkin M, Witt J, Lemonte A, et al. Antigen assay with the potential to aid in diagnosis of blastomycosis. J Clin Microbiol 2004; 42(10):4873Y4875
34. Chapman SW, Bradsher Jr, RW, Campbell GD Jr, et al. Practice guidelines for the management of patients with blastomycosis. Infectious Diseases Society of America. Clin Infect Dis 2000;30(4):679Y683
35. Bradsher RW. Histoplasmosis and blastomycosis. Clin Infect Dis 1996;22(suppl 2): S102YS111
36. Wheat J, Sarosi G, McKinsey D, et al. Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America. Clin Infect Dis 2000;30: 688Y695
37. Chazalet V, Debeaupuis JP, Sarfati J, et al. Molecular typing of environmental and patient isolates of Aspergillus fumigatus from various hospital settings. J Clin icrobiol 1998;36(6):1494Y1500
38. Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 2006;173(7):707Y717
39. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999;12(2): 310Y350
40. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;26(4):781Y803; quiz 804Y805
41. Kleinschmidt-DeMasters BK. Central nervous system aspergillosis: A 20-year retrospective series. Hum Pathol 2002;33(1): 116Y124
42. Jain KK, Mittal SK, Kuman S, Gupta RK. Imaging feature of central nervous system fungal infections. Neurol India 2007;55(3): 214Y250
43. Herbrecht R, Letscher-Bru V, Oprea C, et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002;20(7): 1898Y1906
44. Verweij PE, Stynen D, Rijs AJ, et al. Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J Clin Microbiol 1995;33(7):1912-1914
45. Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004;39(2):199-205
46. Hummel M, Spiess B, Kentouche K, et al. Detection of Aspergillus DNA in cerebrospinal fluid from patients with cerebral aspergillosis by a nested PCR assay. J Clin Microbiol 2006;44(11): 3989-3993
47. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347(6):408-415
48. Marra CM, Boutin P, McArthur JC, et al. A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virusYinfected individuals. Clin Infect Dis 2000;30(3):540-544
49. Turgut M, Ozsunar Y, Oncu S, et al. Invasive fungal granuloma of the brain caused by Aspergillus fumigatus: A case report and review of the literature. Surg Neurol 2008;69(2):169-174; discussion 174
50. Lee J, Hartman M, Kornfeld H. Macrophage apoptosis in tuberculosis. Yonsei Med J 2009;50(1):1-11
51. Rich AR, McCordick HA. The pathogenesis of tuberculous meningitis. Bull Johns Hopkins Hospital 1933;52:5Y37
52. Garg RK. Tuberculous meningitis. Acta Neurol Scand 2010;122(2):75-90
53. Berenguer J, Moreno S, Laguna F, et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 1992;326(10):668-672
54. Garg RK, Sinha MK. Tuberculous meningitis in patients infected with human immunodeficiency virus. J Neurol 2011;258(1):3-13
55. Hosoglu S, Ayaz C, Geyik MF, et al. Tuberculous meningitis in adults: An eleven-year review. Int J Tuberc Lung Dis 1998;2(7):553Y557
56. Yechoor VK, Shandera WX, Rodriguez P, Cate TR. Tuberculous meningitis among adults with and without HIV infection. Experience in an urban public hospital. Arch Intern Med 1996;156(15):1710-1716
57. Thwaites GE, Caws M, Chau TT, et al. Comparison of conventional bacteriology with nucleic acid amplification (amplified Mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy. J Clin Microbiol 2004; 42(3):996-1002
58. World Health Organization. Treatment of tuberculosis: Guidelines for national programmes. 3rd ed. Geneva, Switzerland: World Health Organization, 2002
59. Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 2008;(1):CD002244
60. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004;351(17): 1741-1751
61. Cárdenas G, Soto-Hernández JL, Orozco RV, et al. Tuberculous brain abscesses in immunocompetent patients: Management and outcome. Neurosurgery 2010;67(4): 1081Y1087; discussion 1087
62. Ghanem KG, Workowski KA. Management of adult syphilis. Clin Infect Dis 2011; 53(suppl 3):S110YS128
63. Marra CM, Tantalo LC, Maxwell CL, et al. Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIV-infected individuals. Neurology 2004;63(1):85Y88
64. Rolfs RT, Joesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patient with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. New Engl J Med 1997;337(5): 307Y314
65. Katz DA, Berger JB, Duncan RC. Neurosyphilis. A comparative study of the effects of infection with human immunodeficiency virus. Arch Neurol 2005;50(3):243Y249
66. Centers for Disease Control and Prevention. 2010 Guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 2010:59(RR 12)1Y110
67. Joseph FJ, Scolding NJ. Sarcoidosis of the nervous system. Pract Neurol 2007;7(4): 234Y244
68. Ginat DT, Dhillon G, Almast J. Magnetic resonance imaging of neurosarcoidosis. J Clin Imaging Sci 2011;1:1Y8
69. Muscal E, Brey RL. Neurological manifestations of systemic lupus erythematosus in children and adults. Neurol Clin 2010;28(1):61-73
70. Rhiannon JJ. Systemic lupus erythematosus involving the nervous system: Presentation, pathogenesis, and management. Clinic Rev Allerg Immunol 2008;34(3):356-360
71. Kim JM, Kim KJ, Yoon HS, et al. Meningitis in Korean patients with systemic lupus erythematosus: Analysis of demographics, clinical features and outcomes; experience from affiliated hospitals of the Catholic University of Korea. Lupus 2011;20(5): 531Y536
72. Fragoso-Loyo H, Cabiedes J, Orozco-Narvaez A, et al. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS One 2008;3(10):e3347
73. Al-Araji A. Kidd DP. Neuro-Behçet's disease: Epidemiology, clinical characteristics, and management. Lancet Neurol 2009;8(2): 192Y204
74. Akman-Demir G, Saip S, Siva A. Behçet's disease. Curr Treat Options Neurol 2011; 13(3):290-310
75. Hajj-Ali RA, Singhal AB, Benseler S, et al. Primary angiitis of the CNS. Lancet Neurol 2011;10(6):561-572
76. Hajj-Ali RA. Primary angiitis of the central nervous system: Differential diagnosis and treatment. Best Pract Res Clin Rheumatol 2010;24(3):413-426
77. Chamberlain MC. Neoplastic meningitis. Oncologist 2008;13(9):967-977
78. Glass JP, Melamed M, Chernik NL, Posner JB. Malignant cells in cerebrospinal fluid (CSF): The meaning of a positive CSF cytology. Neurology 1979;29(10):1369-1375
79. Clarke JL, Perez HR, Jacks LM, et al. Leptomeningeal metastases in the MRI era. Neurology 2010;74(18):1449-1454
80. Groves MD. Leptomeningeal disease. Neurosurg Clin N Am 2011;22(1):67Y78